Donna Hallas discusses the Pfizer-BioNTech vaccine booster for children 5 to 11 years old
Contemporary Pediatrics® Editorial Advisory Board member Donna Hallas shares her thoughts on the recent authorization of a Pfizer-BioNTech COVID-19 booster shot for children 5-11 years old.
In a video for Contemporary Pediatrics®, Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discussed the recent FDA amendment of the current emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine which is now authorizing a single booster dose for children 5-11 years old. The Booster will be available to children of this age at least 5 months after completing the primary vaccine series.
Recent Videos
Related Content
